|
|
|
|
The (no) Effect of Dolutegravir on Whole-Body
Insulin Sensitivity, Lipid and Endocrine Profile in Healthy Volunteers
|
|
|
CROI 2024 March 3-6 Denver
Shahid Bukhari1, Roya Movahedi1, James Nesbitt1, Sujin Kang1, Betsabe R Mateos1, Kristine Elecito1, Arnold Xhikola1, Ana Milinkovic1,2, Graeme Moyle1, Marta Boffito1,2, Ruth Byrne1 1Chelsea & Westminster Hospital, United Kingdom, 2Imperial College London, United Kingdom
|
|
|
|
|
|
|